首页|期刊导航|中华医学杂志(英文版)|Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
Xiangyu Zhao Xiaojun Huang Haotian Wu Yifei Cheng Zhengli Xu Yuhong Chen Yingjun Chang Yu Wang Xiaohui Zhang Lanping Xu
中华医学杂志(英文版)2023,Vol.136Issue(16):2011-2013,3.
中华医学杂志(英文版)2023,Vol.136Issue(16):2011-2013,3.DOI:10.1097/CM9.0000000000002764
Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
摘要
引用本文复制引用
Xiangyu Zhao,Xiaojun Huang,Haotian Wu,Yifei Cheng,Zhengli Xu,Yuhong Chen,Yingjun Chang,Yu Wang,Xiaohui Zhang,Lanping Xu..Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia[J].中华医学杂志(英文版),2023,136(16):2011-2013,3.基金项目
This study was supported by grants from the National Natural Science Foundation of China(Nos.82070184 and 82270228)and sponsored by Beijing Nova Program(No.20220484235),Peking University People's Hospital Research and Development Funds(No.RDL2021-01). (Nos.82070184 and 82270228)